Immunotherapy in Gastrointestinal Carcinoma - How to Separate Hope from Hype

Oncol Res Treat. 2018;41(5):264-265. doi: 10.1159/000489048. Epub 2018 Apr 19.
No abstract available

Publication types

  • Editorial
  • Introductory Journal Article

MeSH terms

  • Antineoplastic Agents, Immunological / pharmacology
  • Antineoplastic Agents, Immunological / therapeutic use*
  • Biomarkers, Tumor / analysis
  • Biomarkers, Tumor / antagonists & inhibitors
  • Biomarkers, Tumor / immunology
  • Carcinoma / immunology
  • Carcinoma / pathology
  • Carcinoma / therapy*
  • Costimulatory and Inhibitory T-Cell Receptors / analysis
  • Costimulatory and Inhibitory T-Cell Receptors / antagonists & inhibitors
  • Costimulatory and Inhibitory T-Cell Receptors / immunology
  • Gastrointestinal Neoplasms / immunology
  • Gastrointestinal Neoplasms / pathology
  • Gastrointestinal Neoplasms / therapy*
  • Hope
  • Humans
  • Immunotherapy / methods*
  • Patient Selection*
  • Treatment Outcome

Substances

  • Antineoplastic Agents, Immunological
  • Biomarkers, Tumor
  • Costimulatory and Inhibitory T-Cell Receptors